Metastatic Pancreatic Neuroendocrine Tumors Have Decreased Somatostatin Expression and Increased Akt Signaling

被引：0
|
作者：
Tran, C. [1 ]
Scott, A. [1 ]
Li, G. [1 ]
Sherman, S. [1 ]
Ear, P. H. [1 ]
Howe, J. [1 ]
机构：
[1] Univ Iowa, Dept Surg, Iowa City, IA 52242 USA
来源：
PANCREAS | 2021年 / 50卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
B-1
引用
收藏
页码：441 / 441
页数：1
相关论文
共 50 条
  • [21] Upregulation of Immune Signaling Pathways Differentiates Metastatic From Localized Pancreatic Neuroendocrine Tumors
    Limberg, Jessica
    Verma, Akanksha
    Ullmann, Timothy
    Moore, Maureen
    Stefanova, Dessislava
    Finnerty, Brendan
    Beninato, Toni
    Zarnegar, Rasa
    Elemento, Olivier
    Fahey, Thomas, III
    Min, Irene
    PANCREAS, 2020, 49 (03) : 475 - 475
  • [22] Therapy with radiolabeled somatostatin peptide analogs for metastatic neuroendocrine tumors
    Bushnell, D
    JOURNAL OF GASTROINTESTINAL SURGERY, 2006, 10 (03) : 335 - 336
  • [23] Therapy with radiolabeled somatostatin peptide analogs for metastatic neuroendocrine tumors
    David Bushnell
    Journal of Gastrointestinal Surgery, 2006, 10 : 335 - 336
  • [24] Decreased UCHLI expression as a cytologic biomarker for aggressive behavior in pancreatic neuroendocrine tumors Discussion
    Libutti, Steven K.
    Moore, Maureen D.
    Keutgen, Xavier
    Howe, James R.
    SURGERY, 2018, 163 (01) : 230 - 231
  • [25] Gene Expression of Somatostatin Receptor 4 Predicts Clinical Outcome of Patients with Metastatic Neuroendocrine Tumors Treated with Somatostatin Analogs
    Slaby, Ondrej
    Sachlova, Milana
    Bednarikova, Marketa
    Fabian, Pavel
    Svoboda, Marek
    Vytopilova, Simona
    Valik, Dalibor
    Vyzula, Rostislav
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2010, 25 (02) : 237 - 243
  • [26] Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors
    Song, Ki Byung
    Kim, Song Cheol
    Kim, Ji Hun
    Seo, Dong-Wan
    Hong, Seung-Mo
    Park, Kwang-Min
    Hwang, Dae Wook
    Lee, Jae Hoon
    Lee, Young-Joo
    PANCREAS, 2016, 45 (02) : 187 - 192
  • [27] Epigenetic Regulation of Endogenous Somatostatin Expression in Neuroendocrine Tumors
    Veenstra, Marije J.
    van Koetsveld, Peter
    Dogan, Fadime
    Farrell, William E.
    Lamberts, Steven W. J.
    Feelders, Richard A.
    de Herder, Wouter W.
    Hofland, Leo J.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [28] Loss of UCHL1 Expression Increases Metastatic Potential in Pancreatic Neuroendocrine Tumors
    Finnerty, Brendan
    Moore, Maureen
    Min, Irene
    Seandel, Marco
    Evans, Todd
    Zarnegar, Rasa
    Fahey, Thomas
    PANCREAS, 2017, 46 (03) : 427 - 428
  • [29] Different Hormonal Expression Patterns Between Primary Pancreatic Neuroendocrine Tumors and Metastatic Sites
    Kimura, Hideyo
    Ohtsuka, Takao
    Fujimoto, Takaaki
    Date, Kenjiro
    Matsunaga, Taketo
    Cases, Ana Ines
    Abe, Atsushi
    Mizuuchi, Yusuke
    Miyasaka, Yoshihiro
    Ito, Tetsuhide
    Oda, Yoshinao
    Nakamura, Masafumi
    Tanaka, Masao
    PANCREAS, 2016, 45 (07) : 947 - 952
  • [30] Differential Gene Expression in Metastatic Pancreatic Neuroendocrine Tumors Predicts Novel Therapeutic Agents
    Scott, Aaron
    Weitz, Michelle
    Breheny, Patrick
    Ear, Po Hien
    Darbro, Benjamin
    Brown, Bart
    Braun, Terry
    Li, Guiying
    Amjad, Ume Salma Shaik
    Kaemmer, Courtney
    Maharjan, Chandra Kumar
    Quelle, Dawn
    Bellizzi, Andrew
    Dillon, Joseph
    O'Dorisio, Thomas
    Howe, James
    PANCREAS, 2020, 49 (03) : 485 - 485
12345